FIM
JAZZ icon

Foresters Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Foresters Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$11.4M Buy
89,000
+300
+0.3% +$40.2K 0.23% 155
2019
Q2 		$12.6M Sell
88,700
-1,600
-2% -$215K 0.23% 149
2019
Q1 		$12.9M Buy
90,300
+15,200
+20% +$1.98M 0.23% 149
2018
Q4 		$9.31M Buy
75,100
+36,000
+92% +$5.34M 0.18% 176
2018
Q3 		$6.57M Buy
+39,100
New +$6.72M 0.1% 268

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Foresters Investment Management's JAZZ Position: Q3 2019 in Review

Foresters Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 0.34% in Q3 2019, buying an estimated $40.2K and bringing the position to 89,000 shares worth $11.4M. The position accounts for 0.23% of the portfolio, ranked #155.

Foresters Investment Management first reported a position in JAZZ in Q3 2018 and has held it in 5 quarters since. The position peaked at $12.9M in Q1 2019. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • Foresters Investment Management held 89,000 shares of Jazz Pharmaceuticals worth $11.4M as of Q3 2019.
  • Foresters Investment Management bought 300 Jazz Pharmaceuticals shares in Q3 2019, an estimated $40.2K.
  • Jazz Pharmaceuticals made up 0.23% of Foresters Investment Management's portfolio in Q3 2019, its #155 holding.
  • Foresters Investment Management first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 5 quarters since.
  • Foresters Investment Management's Jazz Pharmaceuticals position peaked at $12.9M in Q1 2019.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Foresters Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.